SCHEMBL7370657

SCHEMBL7370657

CCOC(=O)CCCCCCOc1cccc(-c2ccccc2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.63
HDAC2 Q92769 2/20 0.63
FAAH O00519 1/20 0.58
HDAC3 O15379 1/20 0.57
HDAC4 P56524 1/20 0.57
HDAC7 Q8WUI4 1/20 0.57
HDAC10 Q969S8 1/20 0.57
HDAC11 Q96DB2 1/20 0.57
HDAC8 Q9BY41 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
HDAC9 Q9UKV0 1/20 0.57
HDAC5 Q9UQL6 1/20 0.57
CYSLTR2 Q9NS75 2/20 0.56
CYSLTR1 Q9Y271 2/20 0.56
RXRA P19793 1/20 0.52
RXRB P28702 1/20 0.52
HRH3 Q9Y5N1 6/20 0.52
PDK2 Q15119 1/20 0.52
FFAR4 Q5NUL3 2/20 0.51
FFAR1 O14842 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7047871 0.95 FAAH (0.64) HDAC1HDAC2FAAHHDAC3HDAC4
SCHEMBL8987333 0.91 HDAC1 (0.51) HDAC1HDAC2FAAHHDAC3HDAC4
SCHEMBL4310750 0.88 HDAC3 (0.65) HDAC1HDAC2FAAHHDAC3HDAC4
SCHEMBL27629760 0.87 LTA4H (0.61) HDAC1HDAC2CYSLTR2CYSLTR1
SCHEMBL1171721 0.87 LTA4H (0.61) HDAC1HDAC2CYSLTR2CYSLTR1
SCHEMBL5491821 0.86 LTA4H (0.62) HDAC1HDAC2FAAHCYSLTR2CYSLTR1
SCHEMBL7044798 0.85 HDAC1 (0.64) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL1171676 0.85 CYSLTR2 (0.62) FAAHCYSLTR2CYSLTR1
SCHEMBL15798175 0.84 CYSLTR2 (0.58) FAAHCYSLTR2CYSLTR1PDK2FFAR1
SCHEMBL8355650 0.83 HDAC1 (0.72) HDAC1HDAC2HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed
US-20020103192-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-08-01 US disclosed
WO-2002046129-A2 INHIBITORS OF HISTONE DEACETYLASE ABBOTT LABORATORIES (US) 2002-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020103192-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC4 HDAC1 1/4885HDAC2 7/4885FAAH 1179/4885
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 HDAC1 1/4885HDAC2 4/4885FAAH 2579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.